Literature DB >> 18248350

Conformational movement of F251 contributes to the molecular mechanism of constitutive activation in the C5a receptor.

Saurabh Sen1, Thomas J Baranski, Gregory V Nikiforovich.   

Abstract

The activation mechanism of G-protein-coupled receptors triggered upon binding of a ligand represents a very important 'conformational switch' in the biological array of signal transduction. However, the molecular and functional details for this activation switch remain unknown. Random saturation mutagenesis data on the complement factor 5a receptor has provided a large data set of mutants including several constitutively active mutants. In the present study, we employed computational modeling to rationalize the constitutive activity for two constitutively active mutants, NQ (I124N/L127Q) and F251A, and we then made predictions for a series of mutants that either promote or constrain constitutive activity. Biological testing of the site-directed mutants confirmed most of the predictions of the computational modeling. These results support a molecular mechanism of constitutive activity in complement factor 5a receptor mutants that is associated with conformational changes in a network of residues neighboring F251 as the focal point of origin.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18248350     DOI: 10.1111/j.1747-0285.2008.00630.x

Source DB:  PubMed          Journal:  Chem Biol Drug Des        ISSN: 1747-0277            Impact factor:   2.817


  2 in total

1.  Simplified modeling approach suggests structural mechanisms for constitutive activation of the C5a receptor.

Authors:  Gregory V Nikiforovich; Garland R Marshall; Thomas J Baranski
Journal:  Proteins       Date:  2010-11-30

2.  Complement factor 5a receptor chimeras reveal the importance of lipid-facing residues in transport competence.

Authors:  Jeffery M Klco; Saurabh Sen; Jakob L Hansen; Christina Lyngsø; Gregory V Nikiforovich; Soren P Sheikh; Thomas J Baranski
Journal:  FEBS J       Date:  2009-05       Impact factor: 5.542

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.